PCMA APPLAUDS BIDEN ADMINISTRATION ACTION TO STOP DRUG MANUFACTURER PATENT ABUSES, LOWER PRESCRIPTION DRUG COSTS

Source :: States News Service. July 7, 2022
Publication Year :: 2022
Abstract: WASHINGTON, D.C -- The following information was released by the Pharmaceutical Care Management Association: Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the [...]

Subjects :: Patent law -- Economic aspects
Trademarks -- Economic aspects
Drugs -- Prescribing
Patents -- Economic aspects
Drug abuse -- Economic aspects
Pharmaceutical industry -- Intellectual property
Patent/copyright issue
News, opinion and commentary

Tools